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1. Introduction  
Response-driven adaptive designs are 
used in phase III clinical trials with an 
objective to treat a larger number of 
patients by the eventual better treatment. 
The objective of a phase III trial is to 
compare the performances of two or more 
competing treatments where the patients 
often arrive sequentially into the study. 
Quite often the patients are treated one 
after another and thus the procedure allows 
to use the past allocation-and-response 
history up to any entering patient to 
determine his/her treatment. Thus, the 
adaptive designs have their role to play in 
such a scenario to help us achieve some 
ethical gain by treating a larger number of 
patients by the better treatment. At the 
same time, we also need some significant 
amount of allocation to the worse treatment 
as well as to enable us to make meaningful 
inference about the treatment difference in 
an efficient manner. Adaptive design is all 
about the trade-off between ethical gain 
(which is achieved if a larger number of 
patients are treated by the better treatment) 
and power/efficiency of the follow-up 
inference (which is maximized through 
optimal allocation). 
Quite a few real applications of 
adaptive designs are there with an 
increasing frequency in the recent days. 
Some real applications of adaptive clinical 
trials for dichotomous responses are due to 
Professor M. Zelen (in a breast cancer trial, 
reported by Iglewicz, 1983), Bartlett et al. 
(1985), Tamura et al. (1994), Ware (1989), 
Rout et al. (1993), Muller and Schefer 
(2001) and Biswas and Dewanji (2004). 
Several adaptive designs are available in 
literature, although most of them are 
suitable for binary treatment responses. 
Some of the well-known designs are the 
play-the-winner rule (see Zelen, 1969), the 
randomized play-the-winner rule (see Wei 
and Durham, 1978), the success driven 
design (see Durham, Flournoy and Li, 
1998). For such designs, the expected 
proportion of allocation to the better 
treatment arm is more than 50%, and this 
proportion increases with the increase in 
treatment difference. However, most of 
these designs are birth processes and 
accordingly the variability is too high. In 
fact, the standard deviations of the 
proportion of allocation for these designs 
are so high that an allocation which is less 
than one or two standard deviation(s) from 
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the expectation often leads less than 50% 
patients to be treated by the better 
treatment, in case of a two treatment 
experiment. Recently Ivanova (2003) 
introduced a new adaptive design for two-
treatment allocation, called the drop-the-
loser (DL) rule, which is a death process. 
Consequently, the variation is quite low as 
it is known from the results of stochastic 
processes that death processes have less 
variability than the birth processes. Hu and 
Rosenberger (2003) observed that the drop-
the-loser rule has the smallest variability 
among the available adaptive designs for 
binary responses. 
All the above designs are for binary 
treatment responses. Certainly the amount 
of research on adaptive design is very low 
with more general treatment responses, e.g. 
continuous treatment responses. The reason 
is mostly the complexity that arises with 
such more general responses, the question 
naturally arises is: how to adapt. Here we 
provide a version of the drop-the-loser rule 
applicable for continuous responses where 
some of the covariates can take an 
important role in the responses. Thus, a 
response with an unfavourable covariate 
should get much weight in favour of the 
treatment concerned than the same 
response with a favourable covariate. In 
any realistic design, these aspects are to be 
taken care of. So, for the purpose of 
application, we need a version of the drop-
the-loser rule, which is equipped with 
continuous responses and properly takes 
care of the covariates of the patients. The 
present paper is towards that direction. 
 
 
2A. The set up 
Suppose we have the two competing 
treatments, say A and B, in a phase III 
clinical trial. We have a set up where the 
patients enter sequentially and each 
entering patient is treated either by A or by 
B using some randomisation where the 
probability of allocating any treatment is 
adaptively determined according to the 
state of art based on the data up to that 
stage. Here we have a set up where the 
responses are continuous and a covariate 
vector x  affects the responses. For 
illustration, at this stage, we assume simple 
linear model of responses where the 
covariate vector influences the responses in 
the same way for both the treatments. For 
many types of treatment responses, a 
simple transformation of the response 
variable, e.g. the logarithm of survival time, 
leads to normality. Thus, for simplicity, we 
assume a normally distributed response 
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structure, although this assumption is not 
needed for our development and 
implementation of the technique. 
Normality, of course, brings some elegance 
in the mathematics. Suppose we have n 
patients in the trial. Let iT  be an indicator 
which takes the value 1 or 0 according as 
the i th patient is treated by A or B. 
Consequently, iY  be the response. Thus we 
assume that ),(~ 2σβμ TiAi xNY +  or 
),(~ 2σβμ TiBi xNY +  depending on the 
i th patient is treated by A or B, where ix  
is the covariate vector of the i th patient. 
Such a linear model holds in many real 
situations, either directly or after taking a 
transformation of the data. Note that 
different 2σ  could be one real possibility. 
But we decide to describe our design in a 
simple set up. Such types of extra 
modifications can be done in our approach 
without much additional difficulty. 
Note that, in our model above, the 
treatment difference (see Ware, 1989; Wei 
et al., 1990) is BA μμ − . Our allocation 
design should be such that it will allocate a 
larger number of patients to treatment A if 
0>− BA μμ , and the allocation proportion 
to treatment A should increase with the 
increase in the difference BA μμ − . But we 
should note the covariate values of each 
patient and give appropriate weights to 
them in the allocation design. 
 
2B. The BB design 
In the BB design, the )1( +i st patient 
is treated by treatment A with probability 
,
ˆˆ
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −Φ
Φσ
μμ BiAi  
where BiAi μμ ˆˆ −  is the covariate-adjusted 
estimate of BA μμ −  based on the data up 
to the first i  patients and Φσ  is a scaling 
constant. It is observed in BB (2001) that 
the design works well in terms of 
allocating a larger proportion of patients to 
the better treatment. The design is intuitive 
in nature. The limiting proportion of 
allocation to treatment A is given by 
.* , ⎟⎟⎠
⎞
⎜⎜⎝
⎛ −Φ=
Φσ
μμπ BAABB  
See BB (2001), for details. 
 
2C. Covariate-adjusted drop-the-loser 
design for continuous responses 
It is observed that the DL rule for 
binary responses or continuous responses 
allocates with quite low variability. In the 
light of the comments of Hu and 
Rosenberger (2003) in the context of 
binary responses, we want to see whether 
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the BB design should be used in practice or 
we should use some possible version of the 
DL/CDL rule, applicable for continuous 
responses, in the presence of covariates. 
Here we propose the covariate-adjusted 
continuous drop-the-loser rule (CCDL). 
Our proposed allocation design is as 
follows. 
We start with an urn having one ball 
each of type A, B and I, where I is the 
immigration ball. For the )1( +i st entering 
patient, 0≥i , we draw a ball from the urn, 
and treat the patient by treatment A or B if 
the drawn ball is of type A or B. On the 
other hand, if the drawn ball is of type I, 
we add one ball each of the types A and B 
to the urn, replace the I ball, and draw one 
ball from the urn afresh. We continue this 
procedure until we get a ball of A or B to 
treat the patient accordingly. Let the 
response of the patient be 1+iY , the 
covariate vector is 1+ix , and the indicator of 
allocation is 1+iT . We then replace the 
drawn ball with a probability 
),,( 11111 +++++ = iiiii xTYpp , which is also a 
function of all the accumulated data up to 
the first )1( +i  patients. We then carry out 
the same procedure for the next entering 
patient. 
The all important problem lies in 
determining 1+ip . For this we proceed as 
follows. Let iβˆ  be the estimate of β  up to 
the data of the first i  patients. Then we 
suggest to set 1+ip  as 
( )1 1 1ˆ ,Ti i i ip G Y x cβ+ + += − −  (2.1)
where G  is the cumulative distribution 
function (cdf) of a symmetric random 
variable. Specifically, we can use the cdf of 
a normal distribution with variance 2Φσ . 
Thus, (2.1) reduces to 
.
ˆ
11
1 ⎟⎟⎠
⎞
⎜⎜⎝
⎛ −−Φ=
Φ
++
+ σ
β cxYp i
T
ii
i  (2.2)
Here c  is a constant, which is set to make 
most of the ip -values not too close to 0 or 
1. Thus, a meaningful idea can be to 
choose c  as the prior idea of 2/)( BA μμ + . 
One can sequentially update c  by 
replacing it by 2/)ˆˆ( BiAi μμ + . The choice 
of Φσ  should also be driven by the fact 
that all the ip -values should not too close 
to 0 or 1. Note that a small value of Φσ  
will make the ip -values too sensitive to 
the iY -values, ip  will be close to 0 or 1 
according as 0ˆ 1 <−− − cxY iTii β  or > 0. 
But, on the other hand, a very large value 
of Φσ  will make the ip ’s close to 0.5, 
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irrespective of the corresponding responses, 
thus making the adaptive mechanism very 
week. That is also not desirable. It is the 
experimenter’s task to choose Φσ  
moderately by balancing this tradeoff. 
In the present set up, our data up to 
the i th patients comprises the allocation 
indicators { }iTT ,,1 " , the responses 
{ }iYY ,,1 "  and the covariate vectors 
{ }ixx ,,1 " . We denote the following; 
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and hence 
.ˆ ,
1
, ixyixxi SS
−=β  (2.3)
We use (2.3) and the current patient’s 
response and covariate vector values to 
obtain the ball replacement probability (2.1) 
or (2.2). Note that in such a situation, the 
estimate of the treatment difference, 
BA μμ − , is 
.ˆ)(ˆˆ i
T
BiAiBiAiBiAi xxYY βμμ −−−=−   (2.4) 
Clearly the above covariate-adjusted 
rule is the usual drop-the-loser rule 
(Durham and Ivanova, 2001; Ivanova, 
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2003) with the unconditional probability of 
replacing the ball as 
,
ˆ
11*
1 ⎥⎥⎦
⎤
⎢⎢⎣
⎡
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⎞
⎜⎜⎝
⎛ −−Φ=
Φ
++
+ σ
β cxYEp i
T
ii
i  (2.5)
which depends on 1+ix  if that is assumed to 
be non-stochastic. If, on the other hand, we 
assume a stochastic covariate vector X  
with a distribution function H , then the 
expectation in * 1+ip  in (2.5) is also taken 
over the distribution of X . We denote it by 
*
1, +iAp  or 
*
1, +iBp  according as the patient is 
treated by A or B. Quite naturally, the 
exact expression becomes complicated. 
 
2D. More complicated set up 
In some situations, the responses 
from the two treatments can be influenced 
by the covariates in different ways. This is 
one real possibility which is not studied by 
Bandyopadhyay and Biswas (2001). As a 
simple model we can assume that 
2~ ( , )Ti A i AY N xμ β σ+  or 
2~ ( , )Ti B i BY N xμ β σ+ , for possibly 
different Aβ  and Bβ , depending on the i th 
patient is treated by A or B. In such a 
situation, simply A Bμ μ−  is not the 
treatment difference, instead treatment 
difference can be defined at some 
particular covariate vector x . Let Mx  be 
the (empirical) mean of x  or the most 
probable covariate vector. Then we define 
the treatment difference at Mx  as 
( ),TA B M A Bxμ μ β β− + −  (2.6)
the difference of the expected responses at 
Mx . The estimate of (2.6) can be obtained 
in the usual way as 
ˆ ˆ( ) ( ) ,T TAi Bi M Ai Ai M Bi BiY Y x x x xβ β− + − − −  
where 
1
, ,
ˆ
Ai Axx i Axy iS Sβ −=  and 1, ,ˆ ,Bi Bxx i Bxy iS Sβ −=  
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3. Conclusions 
In this paper we introduced drop-the-
loser type designs for continuous responses 
with covariates. These designs yield 
adaptive allocation for continuous 
responses with smaller variability than the 
existing adaptive design of Bandyopadhyay 
and Biswas (2001). The present work 
assumes a very simple structure where 
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there is no delayed responses, no staggered 
entry. With the presence of all these 
practical logistics the method will be much 
more complicated and we need to adjust 
the rules sensibly to carry out response-
adaptive allocation. The details are under 
study. 
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